Uzm. Dr. Ender Kalacı

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study)

Clinical & Translational Oncology, 2026

DOI 10.1007/s12094-026-04494-3 PMID 42400766 Quelle: OpenAlex

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

Clinical Genitourinary Cancer, 2026

DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Quelle: OpenAlex

Clinicopathological Correlates of High Stromal Tumor-infiltrating Lymphocytes in Luminal Breast Cancer: A Real-world Study

Journal of Oncological Sciences, 2026

DOI 10.37047/jos.galenos.2026.2026-3-11 Frei zugänglicher VolltextQuelle: OpenAlex

Cancer treatment outcomes in solid organ transplant recipients: a single-center retrospective cohort study

BMC Cancer, 2026

DOI 10.1186/s12885-026-16789-3 Quelle: OpenAlex

Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis

Medicina, 2025

DOI 10.3390/medicina61010123 PMID 39859105 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study

Medicine, 2025

DOI 10.1097/md.0000000000043405 PMID 40696651 Frei zugänglicher VolltextQuelle: OpenAlex

Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience

Journal of Chemotherapy, 2024

DOI 10.1080/1120009x.2024.2358458 PMID 38803194 Quelle: OpenAlex

Akut Lenfoblastik Lösemide Allojenik Hematopoietik Kök Hücre Nakli Sonrası Sitomegalovirüs Reaktivasyonunun Etkileri: Retrospektif Bir Analiz

LLM Dergi, 2024

DOI 10.5578/llm.202402138 Quelle: OpenAlex

Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient

Journal of Oncology Pharmacy Practice, 2023

DOI 10.1177/10781552231186748 PMID 37401253 1 Zitation (Europe PMC) Quelle: OpenAlex

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer

Tuberkuloz ve Toraks, 2022

DOI 10.5578/tt.20229803 PMID 35785877 Quelle: OpenAlex

Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study

Journal of Oncological Sciences, 2021

DOI 10.37047/jos.2021-83087 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia.

Experimental and Clinical Transplantation, 2021

DOI 10.6002/ect.2020.0524 PMID 33928875 Quelle: OpenAlex

1716P Do proton pump inhibitors affect the survival outcomes and safety in colorectal cancer patients treated with regorafenib? A single center and real-life experience

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.08.1688 Quelle: OpenAlex

Düzgün N, Kalacı E, Okatan IE, Heper Okçu A. Refractory to Rituximab-Based B-Cell Depletion Therapy on Chronic Skin Manifestations of Systemic Lupus Erythematosus : Case Report. Journal of Dermatology and Clinical Research 2017 May 31.

Quelle: Profilseite auf livhospital.com

KALACI, E., EROĞLU, D. Ş., SEVAL, G. C., ÖZCAN, M., TOPÇUOĞLU, P., TOPRAK, S. K., ... BOZDAĞ, S. C.(2024). Effects of Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia: A Retrospective Analysis. Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.2, 65-72.

Quelle: Profilseite auf livhospital.com